Biotech Investors & VC Firms in North America
1517 firms in this list, with a median first check of $500K. 339 of them lead rounds. Generated from verified public data and updated continuously.
Y Combinator
San FranciscoPre-Seed–Series A$500K
117 people
Andreessen Horowitz
Menlo ParkSeed–Late Stage$500K – $50M
151 people
Alumni Ventures
ManchesterPre-Seed–Late Stage$100K – $10M
98 people
General Catalyst
San FranciscoPre-Seed–Late Stage$30M
211 people
Bessemer Venture Partners
San FranciscoSeed–Late Stage$50K – $100M
254 people
Sequoia Capital
Menlo ParkPre-Seed–Late Stage$100K – $50M
115 people
Lightspeed Venture Partners
Menlo ParkSeed–Late Stage$1M – $5M
107 people
New Enterprise Associates (NEA)
Menlo ParkSeed–Late Stage$200K – $40M
76 people
RA Capital
BostonSeed–Late Stage
283 people
GV (Google Ventures)
Mountain ViewSeed–Late Stage$250K – $50M
110 people
Norwest Venture Partners
Menlo ParkSeed–Late Stage$10M – $30M
183 people
General Atlantic
New YorkSeries B–Late Stage$10M – $1B
279 people
Bain Capital
BostonPre-Seed–Late Stage
275 people
Khosla Ventures
Menlo ParkPre-Seed–Late Stage$100K – $20M
45 people
Transpose Platform Management
San FranciscoPre-Seed–Late Stage
18 people
Kleiner Perkins
Menlo ParkPre-Seed–Late Stage$500K – $15M
30 people
F-Prime Capital
CambridgePre-Seed–Late Stage$3M – $10M
125 people
New Mountain Capital
New YorkGrowth
229 people
Index Ventures
San FranciscoSeed–Late Stage$540K – $10.8M
53 people
TA Associates
BostonGrowth
136 people
SV Angel
San FranciscoPre-Seed–Growth$150K – $20M
12 people
Felicis Ventures
San FranciscoPre-Seed–Growth$500K – $15M
46 people
Valor Equity Partners
ChicagoSeed–Growth
127 people
Sands Capital Ventures
ArlingtonSeed–Late Stage$10M – $30M
190 people
Frequently asked questions
- Who are the top biotech investors & vc firms in north america?
- Top biotech investors & vc firms in north america include Y Combinator, Andreessen Horowitz, Alumni Ventures, General Catalyst, Bessemer Venture Partners, Sequoia Capital, Lightspeed Venture Partners, New Enterprise Associates (NEA) — 1517 firms in total meet the criteria.
- What is the typical first check among biotech investors & vc firms in north america?
- The median first check among the 1517 biotech investors & vc firms in north america tracked here is $500K.
- How many biotech investors & vc firms in north america lead rounds?
- 339 of the 1517 biotech investors & vc firms in north america tracked here lead investment rounds.
Related lists
Investors & VC Firms in North America (13141)Investors & VC Firms in United States (12250)Investors & VC Firms in Europe (5642)Crypto & Web3 Investors & VC Firms (4887)Investors & VC Firms in Global (4438)AI & Machine Learning Investors & VC Firms (4180)SaaS Investors & VC Firms (4077)Fintech Investors & VC Firms (4072)Healthtech Investors & VC Firms (3720)Investors & VC Firms in Asia-Pacific (3656)
Data sourced from public filings and firms' own websites — see our methodology.











.png)


























































































